Browse > Article
http://dx.doi.org/10.5487/TR.2014.30.3.179

The Simplest Flowchart Stating the Mechanisms for Organic Xenobiotics-induced Toxicity: Can it Possibly be Accepted as a "Central Dogma" for Toxic Mechanisms?  

Park, Yeong-Chul (GLP Center, Catholic University of Daegu)
Lee, Sundong (Dept. of Preventive Korean Medicine, School of Korean Medicine, Sangji University)
Cho, Myung-Haing (Laboratory of Toxicology, College of Veterinary Medicine, Seoul National University)
Publication Information
Toxicological Research / v.30, no.3, 2014 , pp. 179-184 More about this Journal
Abstract
Xenobiotics causing a variety of toxicity in biological systems could be classified as two types, inorganic and organic chemicals. It is estimated that the organic xenobiotics are responsible for approximately 80~90% of chemical-induced toxicity in human population. In the class for toxicology, we have encountered some difficulties in explaining the mechanisms of toxicity caused especially by organic chemicals. Here, a simple flowchart was introduced for explaining the mechanism of toxicity caused by organic xenobiotics, as the central dogma of molecular biology. This flowchart, referred to as a central dogma, was described based on a view of various aspects as follows: direct-acting chemicals vs. indirect-acting chemicals, cytochrome P450-dependent vs. cytochrome P450-independent biotransformation, reactive intermediates, reactivation, toxicokinetics vs. toxicodynamics, and reversibility vs. irreversibility. Thus, the primary objective of this flowchart is to help better understanding of the organic xenobiotics-induced toxic mechanisms, providing a major pathway for toxicity occurring in biological systems.
Keywords
Biotransformation; Cytochrome P450; Reactive intermediates; Toxicokinetics vs. toxicodynamics; Reactivation; Reversibility vs. irreversibility;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Djurovic, J. (2012) Biotransformation of the toxic chemical substances. Math. Models Methods Appl. Sci., 91-95.
2 Smith, M.T., Yager, J.W., Steinmetz, K.L. and Eastmondt, D.A. (1989) Peroxidase-dependent metabolism of benzene's phenolic metabolites and its potential role in benzene toxicity and carcinogenicity. Environ. Health Perspect., 82, 23-29.   DOI
3 Glatt, H. (2000) Sulfotransferases in the bioactivation of xenobiotics. Chem. Biol. Interact., 129, 141-170.   DOI   ScienceOn
4 Guengerich, F.P. and Shimada T. (1998) Activation of procarcinogens by human cytochrome P450 enzymes. Mutat. Res., 400, 201-213.   DOI   ScienceOn
5 Ashauer, R. and Escher, B.I. (2010) Advantages of toxicokinetic and toxicodynamic modeling in aquatic ecotoxicology and risk assessment. J. Environ. Monit., 12, 2056-2061.   DOI   ScienceOn
6 Crick, F. (1970) Central dogma of molecular biology. Nature, 227, 561-563.   DOI   ScienceOn
7 Thieffry, D. and Sarkar, S. (1998) Forty years under the central dogma. Trends Biochem. Sci., 23, 312-316.   DOI   ScienceOn
8 Mattick, J.S. (2004) The hidden genetic program of complex organisms. Sci. Am., 291, 60-67.   DOI
9 Guengerich, F.P. (1992) Metabolic activation of carcinogens. Pharmacol. Ther., 54, 17-61.   DOI   ScienceOn
10 Nioi, P. and Hayes, J.D. (2004) Contribution of NAD(P)H: quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loophelix transcription factors. Mutat. Res., 555, 149-171.   DOI   ScienceOn
11 Goetz, M.E. and Luch, A. (2008) Reactive species: A cell damaging rout assisting to chemical carcinogens. Cancer Lett., 266, 73-83.   DOI   ScienceOn
12 Gram, T.G. (1997) Chemically reactive intermediates and pulmonary xenobiotic toxicity. Pharmacol. Rev., 49, 297-341.
13 Tolando, R., Zanovello, A., Ferrara, R., Iley, J.N. and Manno, M. (2001) Inactivation of rat liver cytochrome P450 (P450) by N,N-dimethylformamide and N,N-dimethylacetamide. Toxicol. Lett., 124, 101-111.   DOI   ScienceOn
14 Well, P.G., Kim, P.M., Nicol, C.J., Parman, T. and Winn, LM. (1997) Drug Toxicity in Embryonic Development I; Reactive Intermediates. Springer Berlin Heidelberg Publishing Company, 124, 453-518.
15 Gold, B., Marky, L.M., Stone, M.P. and Williams, L.D. (2006) A review of the role of the sequence-dependent electrostatic landscape in DNA Aakylation patterns. Chem. Res. Toxicol., 19, 1402-1414.   DOI   ScienceOn
16 Shu, Y.Z., Johnson, B.M. and Yang, T.J. (2008) Role of biotransformation studies in minimizing metabolism-related liabilities in drug discovery. AAPS J., 10, 178-192.   DOI
17 van Bladeren, P.J. (2000) Glutathione conjugation as a bioactivation reaction. Chem. Biol. Interact., 129, 61-76.   DOI   ScienceOn
18 Kumar, G.N. and Surapaneni, S. (2001) Role of drug metabolism in drug discovery and development. Med. Res. Rev., 21, 397-411.   DOI   ScienceOn
19 Masubuchi, N., Makino, C. and Murayama, N. (2007) Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediate: correlation of in vitro and in vivo generation of reactive intermediates and in vitro glutathione conjugate formation in rats and humans. Chem. Res. Toxicol., 20, 455-464.   DOI   ScienceOn
20 Liska, D.J. (1998) The Detoxification Enzyme Systems. Altern. Med. Rev., 3. 187-198.
21 Schroer, K., Kittelmann, M. and Lutz, S. (2010) Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis. Biotechnol. Bioeng., 106, 699-706.   DOI   ScienceOn
22 Guengerich, F.P. (2006) Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J., 8, E101-E111.   DOI
23 Zanger, U.M. and Schwab, M. (2013) Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol. Ther., 138, 103-141.   DOI   ScienceOn
24 Orhan, H. and Vermeulen, N.P. (2011) Conventional and novel approaches in generating and characterization of reactive intermediates from drugs/drug candidates. Curr. Drug Metab., 12, 383-394.   DOI   ScienceOn
25 Bertz, R.J. and Granneman, G.R. (1997) Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Clin. Pharmacokinet., 32, 210-258.   DOI   ScienceOn
26 Yan, Z. and Caldwell, G.W. (2001) Metabolic profiling, and cytochrome P450 inhibition &induction in drug discovery. Curr. Top. Med. Chem., 1, 403-425.   DOI
27 Nagarkatti, P.S. and Nagarkatti, M. (1987) Immunotoxicology: Modulation of the immune system by xenobiotics. Def. Sci. J., 37, 235-244.   DOI
28 Srivastava, A., Maggs, J.L., Antoine, D.J., Williams, D.P., Smith, D.A. and Park, B.K. (2010) Role of reactive metabolites in drug-induced hepatotoxicity. Handb. Exp. Pharmacol., 196, 165-194.   DOI   ScienceOn
29 Bolton, J.L., Trush, M.A., Penning, T.M., Dryhurst, G. and Monks, T.J. (2000) Role of quinones in toxicology. Chem. Res. Toxicol., 13, 135-160.   DOI   ScienceOn
30 Lopachin, R.M. and Decaprio, A.P. (2005) Protein Adduct Formation as a Molecular Mechanism in Neurotoxicity. Toxicol. Sci., 86, 214-225.   DOI   ScienceOn
31 Borzelleca, J.F. (2000) Profiles in toxicology. Paracelsus: herald of modern toxicology. Toxicol. Sci., 53, 2-4.   DOI   ScienceOn
32 International Agency for Research on cancer (IARC) Monograph. (2014) Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs. 1, 109.
33 Betharia, S., Corcoran, G.B. and Ray, S.D. (2014) Mechanisms of Toxicity: In Encyclopedia of Toxicology (3rd Ed), Elsevier Publishing Company, pp. 165-175.
34 Liska, D.J., Lyon, M. and Jones, D.S. (2006) Detoxification and biotransformation imbalance, Explore, 2, pp. 112-140.
35 Gregus, Z. and Klaassen, C.D. (2008) Casarett & Doull's Toxicology (7th ed), The Basic Science of Poisons, Unit 1: Basic principle of toxicology, Chapter 3: mechanisms of toxicity, MC GRAW Hill, pp. 35-81.
36 Attia, S.M. (2010) Deleterious effects of reactive metabolites. Oxid. Med. Cell. Longevity, 3, 238-253.   DOI
37 Ashauer, R., Hintermeister, A., O'Connor, I., Elumelu, M., Hollender, J. and Escher, B.I. (2012) Significance of xenobiotic metabolism for bioaccumulation kinetics of organic chemicals in gammarus pulex. Environ. Sci. Technol., 46, 3498-3508.   DOI
38 Park, Y.C. (2010) The molecular and biochemical principles of toxicology. Korean studies Information Publishing Company, Korea, pp. 19-24.
39 Kumar, V., Abba, A.K. and Aster, J.C. (2012) Robbins Basic Pathology (7th Edition), Elsevier, pp. 199-200.
40 Working, P.K. (1989) Mechanistic Approaches in the Study of Testicular Toxicity: Agents that Directly Affect the Testis. Toxicol. Pathol., 17, 452-456.   DOI   ScienceOn
41 Wells, P.G., Bhullera, Y., Chen, C.S., Jeng, W., Kasapinovic, S., Kennedy, J.C., Kim, P.M., Laposa, R.R., McCallum, G.P., Nicol, C.J., Parman, T., Wiley, M.J. and Wong, A.W. (2005) Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species. Toxicol. Appl. Pharmacol., 207, 354-366.   DOI   ScienceOn
42 Evans, T.J. (2013) Small Animal Toxicology (Third Edition), Chapter 2 - Toxicokinetics and Toxicodynamics, Elsevier Publishing Company, pp. 13-19.